Catalyst Wire Dossier Catalyst Wire Dossier

ADDYI

flibanserin · Sprout Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

17 regulatory and trial events tracked for ADDYI, covering 2014-05-19 to 2025-12-13. Get the full timeline:

Most recent: FDA Approved: ADDYI — Supplemental Application (Sprout Pharmaceuticals, Inc.)

See pricing